161 related articles for article (PubMed ID: 32862587)
1. Neutrophil-to-lymphocyte ratio: a hidden gem in predicting neoadjuvant treatment response in locally advanced rectal cancer?
Andras D; Crisan D; Craciun R; Nemes A; Caziuc A; Drasovean R; Seicean R; Scurtu R; Bințințan V; Eniu D; Coman I; Dindelegan G
J BUON; 2020; 25(3):1436-1442. PubMed ID: 32862587
[TBL] [Abstract][Full Text] [Related]
2. Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
Lee JH; Song C; Kang SB; Lee HS; Lee KW; Kim JS
Anticancer Res; 2018 Dec; 38(12):6905-6910. PubMed ID: 30504408
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer.
Duque-Santana V; López-Campos F; Martin-Martin M; Valero M; Zafra-Martín J; Couñago F; Sancho S
Oncology; 2023; 101(6):349-357. PubMed ID: 36273439
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
Dudani S; Marginean H; Tang PA; Monzon JG; Raissouni S; Asmis TR; Goodwin RA; Gotfrit J; Cheung WY; Vickers MM
BMC Cancer; 2019 Jul; 19(1):664. PubMed ID: 31277604
[TBL] [Abstract][Full Text] [Related]
5. Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.
Shen L; Zhang H; Liang L; Li G; Fan M; Wu Y; Zhu J; Zhang Z
Radiat Oncol; 2014 Dec; 9():295. PubMed ID: 25518933
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
Shen J; Zhu Y; Wu W; Zhang L; Ju H; Fan Y; Zhu Y; Luo J; Liu P; Zhou N; Lu K; Zhang N; Li D; Liu L
Med Sci Monit; 2017 Jan; 23():315-324. PubMed ID: 28100902
[TBL] [Abstract][Full Text] [Related]
7. Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
Graziano V; Grassadonia A; Iezzi L; Vici P; Pizzuti L; Barba M; Quinzii A; Camplese A; Di Marino P; Peri M; Veschi S; Alberti S; Gamucci T; Di Gioacchino M; De Tursi M; Natoli C; Tinari N
Breast; 2019 Apr; 44():33-38. PubMed ID: 30611095
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio on Predicting Responsiveness to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.
Liu M; Feng Y; Zhang Y; Liu H
Biomed Res Int; 2022; 2022():3839670. PubMed ID: 36212713
[TBL] [Abstract][Full Text] [Related]
9. Predictive Value of the Neutrophil-Lymphocyte Ratio for Tumor Regression Grade and Prognosis of Local Advanced Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
Li S; Wang D; Wei R; Yu G; Wang X; Jiang Z
Technol Cancer Res Treat; 2023; 22():15330338231202611. PubMed ID: 37807729
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil-to-Lymphocyte Ratio (NLR) as a Poor Predictive Biomarker for Pathological Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Prospective Study.
Novin K; Fadavi P; Mortazavi N; Sanei M; Khoshbakht Ahmadi H; Barahman M; Noori R; Hoveidamanesh S; Shahin M; Taghizadeh-Hesary F
Asian Pac J Cancer Prev; 2023 Jan; 24(1):61-67. PubMed ID: 36708552
[TBL] [Abstract][Full Text] [Related]
11. Systemic Inflammatory Response After Preoperative Chemoradiotherapy Can Affect Oncologic Outcomes in Locally Advanced Rectal Cancer.
Lee IH; Hwang S; Lee SJ; Kang BW; Baek D; Kim HJ; Park SY; Park JS; Choi GS; Kim JC; Cho SH; Kim JG
Anticancer Res; 2017 Mar; 37(3):1459-1465. PubMed ID: 28314318
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil-to-Lymphocyte Ratio in Rectal Cancer-Novel Biomarker of Tumor Immunogenicity During Radiotherapy or Confounding Variable?
Braun LH; Baumann D; Zwirner K; Eipper E; Hauth F; Peter A; Zips D; Gani C
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108935
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Role of Peripheral Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy.
Ergen ŞA; Barlas C; Yıldırım C; Öksüz DÇ
J Gastrointest Cancer; 2022 Mar; 53(1):151-160. PubMed ID: 33392960
[TBL] [Abstract][Full Text] [Related]
14. Association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with ER and PR in breast cancer patients and their changes after neoadjuvant chemotherapy.
Xu J; Ni C; Ma C; Zhang L; Jing X; Li C; Liu Y; Qu X
Clin Transl Oncol; 2017 Aug; 19(8):989-996. PubMed ID: 28247194
[TBL] [Abstract][Full Text] [Related]
15. Predicting the Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Using Soluble Immune Checkpoints.
Ari A; Sevik H; Sevinc MM; Tatar C; Buyukasik K; Surel AA; Idiz UO
Cancer Biother Radiopharm; 2024 Apr; 39(3):247-254. PubMed ID: 38010745
[No Abstract] [Full Text] [Related]
16. Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapy.
Kim TG; Park W; Kim H; Choi DH; Park HC; Kim SH; Cho YB; Yun SH; Kim HC; Lee WY; Lee J; Kang KM
Tumori; 2019 Oct; 105(5):434-440. PubMed ID: 30117371
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of platelet-associated biomarkers in rectal cancer patients received neoadjuvant chemoradiation: A retrospective study.
Wang P; Wang Z; Liu Y; Xie J; Ren Y
Cancer Radiother; 2021 Apr; 25(2):147-154. PubMed ID: 33423969
[TBL] [Abstract][Full Text] [Related]
18. COMPLETE BLOOD COUNT DERIVED INFLAMMATORY BIOMARKERS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES.
Nanava N; Betaneli M; Giorgobiani G; Chikovani T; Janikashvili N
Georgian Med News; 2020 May; (302):39-44. PubMed ID: 32672687
[TBL] [Abstract][Full Text] [Related]
19. A study of inflammation-based predictors of tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Krauthamer M; Rouvinov K; Ariad S; Man S; Walfish S; Pinsk I; Sztarker I; Charkovsky T; Lavrenkov K
Oncology; 2013; 85(1):27-32. PubMed ID: 23816828
[TBL] [Abstract][Full Text] [Related]
20. An inflammation index-based prediction of treatment response to neoadjuvant chemoradiotherapy for rectal mucinous adenocarcinoma.
Sun Y; Huang Z; Chi P
Int J Clin Oncol; 2020 Jul; 25(7):1299-1307. PubMed ID: 32274615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]